MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Guardant Health ROCE Ratio 2011-2026 | GH
Annual ROCE Ratio Guardant Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 440.3 | 317.65 | -355.88 | -904.58 | -63.72 | -19.63 | -9.26 | -17.2 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 440.3 | -904.58 | -76.54 |
Quarterly ROCE Ratio Guardant Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 174.05 | 302.27 | 6512.29 | 6331.47 | 6287.2 | 6237.46 | 6001.36 | 64.32 | 210.31 | 123.59 | 132.48 | 150.2 | -150.7 | -165.82 | -91.49 | -63.39 | -40.25 | -45.97 | -35.05 | -25.35 | -12.61 | -14.8 | -11.0 | -9.75 | -7.07 | -12.08 | -14.59 | -16.53 | -13.57 | -22.86 | -4.7 | -3.86 | - | -9.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6512.29 | -165.82 | 962.31 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 115.84 | 0.68 % | $ 35.2 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 133.97 | -0.22 % | $ 6.26 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 7.3 | -19.87 % | $ 9.71 M | USA |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 21.26 | 7.97 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
-8.19 | $ 17.9 | 1.3 % | $ 551 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 22.16 | 2.88 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.8 | - | $ 7.96 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
11.53 | $ 118.45 | 4.04 % | $ 9.77 B |  Irlanda |
 |
Illumina
ILMN
|
-35.1 | $ 150.17 | 3.41 % | $ 23.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 99.09 | -0.97 % | $ 6.69 B | USA |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 093.84 | -0.68 % | $ 22.5 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 164.49 | 4.95 % | $ 8.15 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 9.57 | 3.24 % | $ 1.23 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 428.0 | -0.26 % | $ 12.3 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 19.13 | 0.47 % | $ 428 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 203.11 | 1.1 % | $ 20 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 3.94 | 2.34 % | $ 365 M | USA |
 |
Personalis
PSNL
|
-33.71 | $ 9.49 | 6.15 % | $ 847 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 26.6 | -1.26 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.32 | -1.71 % | $ 264 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 64.17 | -1.08 % | $ 3.84 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.46 | -0.61 % | $ 5.65 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 258.25 | -0.08 % | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 456.21 | 1.79 % | $ 172 B | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 342.18 | 1.05 % | $ 20.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.68 | 5.04 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.2 | 0.66 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 193.99 | 0.58 % | $ 21.5 B | USA |